Association of Neutrophil to Lymphocyte Ratio With Plaque Rupture in Acute Coronary Syndrome Patients With Only Intermediate Coronary Artery Lesions Assessed by Optical Coherence Tomography

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Mar 31

PMID 35355959

Authors

Jintong Jiang

Huasu Zeng

Yang Zhuo

Changqian Wang

Jun Gu

Junfeng Zhang

Huili Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: Plaque vulnerability and rupture rather than plaque size are the major cause of clinical events in patients with intermediate coronary lesions. Therefore, the present study was aimed to explore potential markers associated with plaque rupture in acute coronary syndrome (ACS) patients with intermediate coronary lesions.

Methods: A total of 82 ACS patients presenting with only intermediate coronary lesions (40-70% stenosis demonstrated by quantitative coronary angiography) and no severe stenosis in other main coronary arteries [median age 63 years, 53 male and 29 female] were enrolled. Plaque morphology were assessed by optical coherence tomography (OCT). Hematological indices were assayed by automated hematological analyzer.

Results: Plaque rupture was identified in 14 patients by OCT. Neutrophil to lymphocyte ratio (NLR) in patients with plaque rupture ( = 14) was significantly higher than that in patients with non-plaque rupture ( = 68) [3.85 (3.28, 4.77) vs. 2.13 (1.40, 2.81), < 0.001]. Multivariate logistic regression analysis revealed that NLR was one of the independent risk factors for plaque rupture in intermediate coronary artery lesions (odds ratio 1.64, 95% confidence intervals 1.18-2.29, = 0.003). ROC curve analysis found a cutoff point of NLR > 2.94 for plaque rupture with 93.8% sensitivity and 77.9% specificity.

Conclusion: NLR, an inflammatory biomarker, is closely associated with plaque rupture in intermediate coronary artery lesions. Monitoring NLR may be useful in risk stratification and management for intermediate coronary artery lesions.

Citing Articles

Inflammation Biomarker-Driven Vertical Visualization Model for Predicting Long-Term Prognosis in Unstable Angina Pectoris Patients with Angiographically Intermediate Coronary Lesions.

Zhou B, Tan W, Duan S, Wang Y, Bian F, Zhao P J Inflamm Res. 2024; 17:10571-10584.

PMID: 39659751 PMC: 11629667. DOI: 10.2147/JIR.S497546.

Evaluation of Estimated Glucose Disposal Rate with Neutrophil-to-Lymphocyte Ratio Integrated for Prognosticating Adverse Cardiovascular and Cerebrovascular Events and Risk Stratification Among Acute Coronary Syndrome with Type 2 Diabetes Mellitus....

Feng X, Liu Y, Yang J, Zhou Z, Yang S, Zhou Y J Inflamm Res. 2024; 17:9193-9214.

PMID: 39588140 PMC: 11586482. DOI: 10.2147/JIR.S490790.

References

Adamstein N, MacFadyen J, Rose L, Glynn R, Dey A, Libby P . The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021; 42(9):896-903. PMC: 7936519. DOI: 10.1093/eurheartj/ehaa1034. View

Tearney G, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra H . Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012; 59(12):1058-72. DOI: 10.1016/j.jacc.2011.09.079. View

Wang Y, Peng Z . Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study. Medicine (Baltimore). 2021; 100(33):e26942. PMC: 8376371. DOI: 10.1097/MD.0000000000026942. View

Duffy B, Gurm H, Rajagopal V, Gupta R, Ellis S, Bhatt D . Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006; 97(7):993-6. DOI: 10.1016/j.amjcard.2005.10.034. View

Mor A, Luboshits G, Planer D, Keren G, George J . Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J. 2006; 27(21):2530-7. DOI: 10.1093/eurheartj/ehl222. View

Patel M, Peterson E, Dai D, Brennan J, Redberg R, Anderson H . Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010; 362(10):886-95. PMC: 3920593. DOI: 10.1056/NEJMoa0907272. View

Gibson P, Croal B, Cuthbertson B, Small G, Ifezulike A, Gibson G . Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007; 154(5):995-1002. DOI: 10.1016/j.ahj.2007.06.043. View

Burke A, Farb A, Malcom G, Liang Y, Smialek J, Virmani R . Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997; 336(18):1276-82. DOI: 10.1056/NEJM199705013361802. View

Nunez J, Nunez E, Bodi V, Sanchis J, Minana G, Mainar L . Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008; 101(6):747-52. DOI: 10.1016/j.amjcard.2007.11.004. View

10.

Pijls N, van Schaardenburgh P, Manoharan G, Boersma E, Bech J, Vant Veer M . Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol. 2007; 49(21):2105-11. DOI: 10.1016/j.jacc.2007.01.087. View

11.

Csordas A, Bernhard D . The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013; 10(4):219-30. DOI: 10.1038/nrcardio.2013.8. View

12.

Mintz G . Clinical utility of intravascular imaging and physiology in coronary artery disease. J Am Coll Cardiol. 2014; 64(2):207-22. DOI: 10.1016/j.jacc.2014.01.015. View

13.

Dragu R, Huri S, Zukermann R, Suleiman M, Mutlak D, Agmon Y . Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis. 2006; 196(1):405-412. DOI: 10.1016/j.atherosclerosis.2006.11.022. View

14.

Kolodgie F, Burke A, Farb A, Gold H, Yuan J, Narula J . The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001; 16(5):285-92. DOI: 10.1097/00001573-200109000-00006. View

15.

Drechsler M, Megens R, van Zandvoort M, Weber C, Soehnlein O . Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010; 122(18):1837-45. DOI: 10.1161/CIRCULATIONAHA.110.961714. View

16.

Doring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S . Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res. 2012; 110(8):1052-6. DOI: 10.1161/CIRCRESAHA.112.265868. View

17.

Tamhane U, Aneja S, Montgomery D, Rogers E, Eagle K, Gurm H . Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008; 102(6):653-7. DOI: 10.1016/j.amjcard.2008.05.006. View

18.

Critchley J, Capewell S . Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003; 290(1):86-97. DOI: 10.1001/jama.290.1.86. View

19.

Bae J, Corban M, Seo Y, Kim T, Lee G, Kwon T . Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events. Int J Cardiol. 2019; 299:26-30. DOI: 10.1016/j.ijcard.2019.06.076. View

20.

Azab B, Shah N, Akerman M, McGinn Jr J . Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012; 34(3):326-34. DOI: 10.1007/s11239-012-0718-6. View